Brief: Xbrane Biopharma Q2 pre-tax loss widens to SEK 9.4 million

Xbrane Biopharma AB

31/08/2017 09:32

Aug 31 (Reuters) - XBRANE BIOPHARMA AB  XBRANE.ST  
    * APRIL-JUNE NET SALES SEK 4.5 MILLION VERSUS SEK 1.0 MILLION YEAR AGO 
    * Q2 PRE-TAX LOSS SEK 9.4 MILLION VERSUS LOSS SEK 7.6 MILLION YEAR AGO 
 
Source text for Eikon:  ID:nGNE4cn6d9  
Further company coverage:  XBRANE.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))